Kenneth L Kirsh
Overview
Explore the profile of Kenneth L Kirsh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosenfeld B, Budescu D, Han Y, Foellmi M, Kirsh K, Passik S
Subst Abus
. 2019 Jun;
41(1):85-92.
PMID: 31206353
Urine drug testing techniques have different rates of false-positive and false-negative test results. However, clinicians may have highly varying perceptions of test accuracy and may compensate for perceived inaccuracy by...
2.
Lowery-Allison A, Passik S, Cribbet M, Reinsel R, OSullivan B, Norton L, et al.
Palliat Support Care
. 2017 May;
16(3):325-334.
PMID: 28508735
Method: A total of 200 patients at a comprehensive cancer center who were 1-10 years posttreatment for primary stage I-III breast cancer with no evidence of disease at the time...
3.
Rzetelny A, Zeller B, Miller N, Kirsh K, Passik S
J Addict Med
. 2016 Sep;
10(6):443-447.
PMID: 27649263
Clinical drug monitoring has an increasingly important role in the treatment of substance use disorders. Through semistructured interviews, we asked substance-use counselors about the clinical impact of drug tests on...
4.
Chambers J, Gleason R, Kirsh K, Twillman R, Webster L, Berner J, et al.
Pain Med
. 2016 Jan;
17(9):1686-93.
PMID: 26814291
Objective: To conduct an Internet patient survey through the National Fibromyalgia & Chronic Pain Association on reactions to the first 100 days following the rescheduling of hydrocodone. Methods: Face-valid survey...
5.
Rzetelny A, Zeller B, Miller N, City K, Kirsh K, Passik S
Int J Ment Health Addict
. 2016 Jan;
14:64-80.
PMID: 26798328
We conducted a psychotherapeutic examination of the use of definitive drug testing (liquid chromatography with tandem mass spectrometry) in the treatment of substance use disorders (SUD). Employing a generic qualitative...
6.
Kirsh K, Baxter L, Rzetelny A, Mazuk M, Passik S
J Addict Med
. 2015 Sep;
9(5):399-404.
PMID: 26335003
Objectives: Urine drug testing (UDT) can play an important role in addiction medicine. Indeed, the American Society of Addiction Medicine (ASAM) recently released a white paper, detailing the history of...
7.
Peppin J, Cheatle M, Kirsh K, McCarberg B
Pain Med
. 2015 Mar;
16(4):653-66.
PMID: 25752874
Objective: More than 25% of the US population experiences chronic pain; yet few physicians specialize in the field of pain medicine. This article will review a theoretical model of care...
8.
Passik S, Kirsh K, Twillman R
J Opioid Manag
. 2015 Mar;
11(1):77-81.
PMID: 25750168
Objective: Both prescription drug monitoring programs (PDMP) and urine drug testing (UDT) are recommended as parts of an ongoing risk management approach for controlled substance prescribing. The authors provide an...
9.
Kirsh K, Heit H, Huskey A, Strickland J, Egan K, Passik S
J Opioid Manag
. 2015 Mar;
11(1):61-8.
PMID: 25750166
Objective: Urine drug testing (UDT) can play an important role in the care of patients in recovery from addiction, and it has become necessary for providers and programs to utilize...
10.
Kirsh K, Christo P, Heit H, Steffel K, Passik S
J Opioid Manag
. 2015 Mar;
11(1):53-9.
PMID: 25750165
Objective: To discuss the importance of specimen validity testing (SVT) in urine drug testing (UDT) and the clinical role it plays in identifying efforts to subvert the UDT process. Methods:...